Providing Better Immunology Tools For Better Healthcare  ::  

Company Management

ETI Management

Gregory Pogue, Ph.D.
Gregory Pogue, Ph.D.
President, Pure Vaccine Solutions
Executive Vice President, Pure Protein
William C. Streiber
William C. Strieber
Executive Vice President, Pure Transplant Solutions
 

Portfolio Company Personnel

Rico Buchli, Ph.D.
Rico Buchli, Ph.D.
Director of Research
Pure Protein and Subsidiaries
 
 

 

Pure Protein , L.L.C., is an Emergent Technologies Inc. (ETI) portfolio company and ETI provides all management services and operations support.

About Emergent Technologies, Inc.

Headquartered in Austin, Texas, Emergent Technologies, Inc. (ETI) is a life sciences technology investment and management company which provides early stage funding and development for scientific discoveries originating at universities and research institutions. The Company creates value by transforming scientific breakthroughs into technology platforms with multiple applications. ETI's unique innovation process enables the Company to select promising scientific discoveries for development, maximize the value of intellectual property and manage both cost and risk associated with the commercial development of early stage technologies. ETI is dedicated to turning research into revenue and, in the process, introducing compelling solutions to meet important market needs. For more information, visit the company website www.etibio.com